
NAD vs NMN: which one should you actually take?
Why you cannot efficiently swallow NAD⁺ itself, what NMN does differently, and what the FDA's September 2025 reversal changed.
Read the comparisonEvery major precursor and delivery format, compared without the biohacker hype or the supplement-industry spin.
NAD⁺ is the coenzyme your mitochondria run on. It declines with age. Everyone agrees on that part. The disagreement — and the whole reason this site exists — is which precursor, in which format, is worth your money.
Nicotinamide Mononucleotide
One enzymatic step from NAD⁺, and the subject of more longevity buzz than any other precursor. Lawful as a US supplement again since the FDA's September 2025 reversal.
Nicotinamide Riboside
The incumbent. Sold under the Niagen name by ChromaDex, two enzymatic steps from NAD⁺, with the longest clean regulatory record of the common precursors.
The same milligram figure on two different labels can mean very different amounts reaching your bloodstream. The format is most of the story.
The unglamorous default: cheapest per dose, easiest to keep up, and the format most human research used.
Format 02Skips first-pass metabolism for the fraction absorbed under the tongue. A real edge, smaller than marketed.
Format 03The at-home middle ground: skips digestion entirely. Prescription-only in the US.
Format 04Complete delivery over several hours in a clinic chair. The least practical habit to repeat.
Format 05Nose-to-brain delivery is real research. For NAD⁺ precursors, the evidence is not there yet.
Format 06The one format to skip, for reasons of molecular size and skin physiology.
Every brand claims theirs is the "most bioavailable." Every biohacker on YouTube has "the one protocol that works." Some of the research is funded by the companies selling the supplement.
We cite the peer-reviewed research. We show you how to work out cost per milligram. We flag conflicts of interest. When a comparison is genuinely a toss-up, we say so — instead of picking the one with the highest affiliate payout.
How we workNew comparisons, format deep-dives, and protocol notes.

Why you cannot efficiently swallow NAD⁺ itself, what NMN does differently, and what the FDA's September 2025 reversal changed.
Read the comparison
Falling NAD⁺ is mostly a consumption problem, not a production one, and that changes what is worth taking.
Read the science
Morning dosing has a real circadian rationale. The with-or-without-food question is mostly folklore.
Read the protocolAnswer four questions and we'll point you at the delivery format most likely to fit your goal, budget and tolerance for process.
Take the format finder